Our reports provide an independent, expert view supported by robust and innovative data interrogation and analysis.

Refine Sector
Sub-Category
Clear
Publish Date
Clear
Region
Clear
Clear All

You have Selected

Keywords :all reports [X]
Industry :Archive [X]
Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth

Published: Dec-2012

GBI Research, the leading business intelligence provider, has released its latest research: “Rheumatology Therapeutics.....

$3500
More Info
Pharmaceutical Supply Chain in the US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits

Published: Jun-2012

GBI Research, the leading business intelligence provider, has released its new report “Pharmaceutical Supply Chain in.....

$3500
More Info
Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance, to Enhance Patient Compliance

Published: Sep-2011

The GBI Research’s report on, “Post Marketing Clinical Research-REMS, the Latest Reformation due to Post Marketing Surveillance.....

$3500
More Info
Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS

Published: May-2011

GBI Research's research, “Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and.....

$3500
More Info
The Global Carbon Trading Market: Concepts, Regulations and Industry Trends to 2020

Published: Apr-2010

GBI Research’s report, “The Global Carbon Trading Market - Concepts, Regulations and Industry Trends to 2020” provides.....

$1000
More Info